Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000597091 | SCV000709699 | likely pathogenic | not provided | 2017-09-07 | criteria provided, single submitter | clinical testing | The R2870X nonsense variant in the EYS gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It is predicted to cause loss of normal protein function through protein truncation. The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In summary, we consider this variant to be likely pathogenic. |
Invitae | RCV000597091 | SCV000959359 | pathogenic | not provided | 2023-11-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg2849*) in the EYS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 296 amino acid(s) of the EYS protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 503517). This variant disrupts a region of the EYS protein in which other variant(s) (p.Tyr2935*) have been determined to be pathogenic (PMID: 22363543, 24652164, 28763560). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV002248812 | SCV002519632 | pathogenic | Retinitis pigmentosa 25 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003889932 | SCV004707398 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Baylor Genetics | RCV002248812 | SCV005060480 | pathogenic | Retinitis pigmentosa 25 | 2024-02-14 | criteria provided, single submitter | clinical testing |